Genetic variation in RNASEL associated with prostate cancer risk and progression. - Wikidata - awgldk - TriplyDB

Genetic variation in RNASEL associated with prostate cancer risk and progression.

Genetic variation in RNASEL associated with prostate cancer risk and progression.

http://www.wikidata.org/entity/Q34094981

about

New insights into the role of RNase L in innate immunity Genetic variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF genes are prognostic markers of prostate cancer-specific mortality.Genetic variation across C-reactive protein and risk of prostate cancer.Detection of infectious organisms in archival prostate cancer tissues.Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response Identification of genetic risk associated with prostate cancer using ancestry informative markers Genetic variation in RNASEL and risk for prostate cancer in a population-based case-control study Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial Short communication: RNASEL alleles and susceptibility to infection by human retroviruses and hepatitis viruses.Pathologic effects of RNase-L dysregulation in immunity and proliferative control.Profiles of microRNA networks in intestinal epithelial cells in a mouse model of colitis.Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: a nested case-control study.Family History of Cancer in Relation to Breast Cancer Subtypes in African American Women A single nucleotide polymorphism in inflammatory gene RNASEL predicts outcome after radiation therapy for localized prostate cancer.Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial.The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients.The link between benign prostatic hyperplasia and prostate cancer.Evolutionary adaptation revealed by comparative genome analysis of woolly mammoths and elephants.Gene panel model predictive of outcome in patients with prostate cancer.Xenotropic Murine Leukemia Virus-Related Virus and RNase L R462Q Variants in Iranian Patients With Sporadic Prostate Cancer.RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.Association of a common genetic variant in RNASEL and prostate cancer susceptibility.Local and systemic inflammation may mediate diesel engine exhaust induced lung function impairment in a Chinese occupational cohort.Immunogenetics of prostate cancer: a still unexplored field of study.

P2860

Q24597466-9E48852E-13A3-4874-80A1-22AAACE0A43E Q30504100-2D7D650C-CA9C-4F48-8B85-AC4E7C08D999 Q33777217-6DFF40B3-0D72-4D10-ACB9-07560E3980E9 Q34045208-39348E43-6342-4BEA-A937-149671E09ABD Q34308746-E5118F81-8EDE-49B7-AC02-47AAD90B30F7 Q34580412-55A21704-AE2C-47F1-A3AE-799C0A75E81C Q34918166-4D438E9A-8215-4E34-847C-1AB6BF0CBB40 Q35089535-923A453B-8150-4D8D-B0A8-6AAB44DD2E67 Q35091272-0DDB328F-CFBD-486C-9ED7-9C5A88355FBD Q35952102-19DE469F-B3B0-40F0-BF57-BA02C22CF139 Q36250391-EF0CDC47-1FD8-4DC9-8419-C72C48E2CB91 Q36310770-EB9FFECE-F93D-4D02-B4A4-3BDEE71C33F8 Q36357175-C328928A-A2E4-4B68-B381-E2931FCD5E4A Q36486486-4B427965-46CA-45B3-866A-19184F0A7B1B Q36619735-BDFC823A-DCDE-4FC7-9977-E3AD4F45F896 Q36699077-CBDE7625-F380-4339-8047-2AE0C2902C84 Q36827156-381FD061-E1B5-47B1-A4FD-9CC99EE84C39 Q37170826-74C814CE-9A77-41EE-AF23-D6BBD03236AD Q38061029-5C87E1EB-8E42-47C4-B524-BC466E869AEE Q38693643-E8D744CD-307C-422B-98BE-9C2BC0F17CD0 Q39403730-ED8059C1-9CC9-4AD9-A0D4-89C66DAB6913 Q40991532-2A75DF0C-686B-4F7C-BA87-B67BE7AAFA37 Q44895615-926DFD96-9600-42FA-AC1A-35ADEB2428C5 Q46949052-42A6A9CB-BF04-4E8F-AEDE-E090F14EAADF Q47302400-092736E3-5D48-4B73-9B99-95A2D8987C0F Q50082109-664E3E05-CA28-4210-9A4B-E152E6F5F64F

P2860

Genetic variation in RNASEL associated with prostate cancer risk and progression.

http://www.wikidata.org/entity/Q34094981

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@ast

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@en

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@nl

type

label

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@ast

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@en

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@nl

prefLabel

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@ast

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@en

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@nl

P1433

Q34094981-FA4C86EE-95F3-4B2C-99DC-CBC77421BDAB

P1476

Q34094981-8F7A5C66-FBA6-4D80-812B-E8A6E3081835

P2093

Q34094981-094B138B-F243-4983-BB69-14FA667ACDDC

Q34094981-160360DC-7B2A-4789-906A-DBAEFB6B114B

Q34094981-3562D3A4-6950-4075-8D03-46E572655534

Q34094981-7BEDC3B6-31F6-450A-A775-DC858FBDEEBF

Q34094981-99AECCC2-4668-4D4C-BB65-E006FCF6B033

Q34094981-B5D43076-0E44-43B9-BA55-F417336D350E

Q34094981-BD3F5FBA-9FEF-4E29-9B5B-8937AEED53DB

P2860

Q34094981-04EC1B4F-5A89-49FB-B1A4-8322604F4B6C

Q34094981-0BDDD435-8FC0-4678-BC21-9C19DC95F20F

Q34094981-280101BE-DAEB-43B4-B3D3-31F990AA260F

Q34094981-333E7887-892D-4247-BEC0-6C300F22CDBF

Q34094981-3370242D-78F4-4690-8DA4-AA61946DDA53

Q34094981-34122F56-4350-481E-A0D6-2018D96AAAC6

Q34094981-3A43EC74-0628-424A-AD1A-9768314ABDBA

Q34094981-3B177FB6-21C4-4055-A551-AE6E7F996514

Q34094981-3C82C7D9-65D8-4D6B-B679-E17ACD426996

Q34094981-40C7C8DF-6A5A-4D49-AC4F-F2EBD699E605

P304

Q34094981-8C56E809-6CDD-41F4-AA8E-3A0DD6CFE39F

P31

Q34094981-0C4875ED-928B-49C3-BC05-A56FE7BB714D

P356

Q34094981-796987CF-0E0D-44AF-B727-14CA74EA0121

P407

Q34094981-ED2BB4C5-DD03-4E0B-9ACB-D6A376012E77

P433

Q34094981-838837C4-84C3-4F7D-B0C6-3180811D4EFE

P478

Q34094981-EF91D456-ADF3-478D-BB73-E5E99B7F332B

P50

Q34094981-02BDCF11-B9B1-4DBC-9020-BCC193DB350E

Q34094981-244D20B2-061D-4591-9D99-1AC9EB1424EA

Q34094981-4A929E9B-627A-4299-95E2-76C34B88B494

Q34094981-5332C216-1B97-44F6-AFE2-3D7F30F4E2AA

Q34094981-5BFBDB19-072D-4AF2-9192-3511CA81BC73

Q34094981-A996409E-40C1-4BE2-A06F-BED854E392CA

Q34094981-C602DDD4-BFBC-487C-B4A6-80D29B7C4598

Q34094981-C82E2495-8681-4468-AB8D-02468C3C5077

Q34094981-D969FF31-BE51-4BE0-928E-11718D46E5DB

P577

Q34094981-63BBE057-FDAE-4F5F-A9CF-CB767F5E2252

P5875

Q34094981-763A701A-505F-4614-ABCE-6077A627F0E3

P698

Q34094981-9C23540A-A605-4981-BA96-38035D182957

P932

Q34094981-8990EFD3-802E-455A-BFAD-4CB9A8E3A9D6

P356

P1433

P1476

Genetic variation in RNASEL associated with prostate cancer risk and progression.

@en

P2093

Alkes L Price

http://www.w3.org/2001/XMLSchema#string

Fredrick R Schumacher

http://www.w3.org/2001/XMLSchema#string

Howard D Sesso

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

Kathryn L Penney

http://www.w3.org/2001/XMLSchema#string

Mara S Meyer

http://www.w3.org/2001/XMLSchema#string

Michelangelo Fiorentino

http://www.w3.org/2001/XMLSchema#string

P2860

RETRACTED: Identification of a novel Gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant.

A scientific journey through the 2-5A/RNase L system

SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes

Germline mutations in the ribonuclease L gene in families showing linkage with HPC1

Prevalence of human gammaretrovirus XMRV in sporadic prostate cancer

Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search

Multiple loci identified in a genome-wide association study of prostate cancer

C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older

Interferon action and apoptosis are defective in mice devoid of 2',5'-oligoadenylate-dependent RNase L

Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.

P304

1597-1603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGQ132

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Stephen P. Finn

Jennifer R Stark

Lorelei A Mucci

Meir J Stampfer

P577

2010-06-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44798851

http://www.w3.org/2001/XMLSchema#string

P698

20576793

http://www.w3.org/2001/XMLSchema#string

P932

2930803

http://www.w3.org/2001/XMLSchema#string